We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-5.72%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.95B
AUM Growth
+$407M
Cap. Flow
+$737M
Cap. Flow %
9.28%
Top 10 Hldgs %
63.45%
Holding
409
New
72
Increased
88
Reduced
65
Closed
155

Top Buys

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$49.7M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$49.3M
3
IMCR icon
Immunocore
IMCR
+$41.4M
4
EXAS
Exact Sciences
EXAS
+$36.8M
5
IMVT icon
Immunovant
IMVT
+$35.1M

Top Sells

Rank Stock Value
1
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$92.8M
2
KO icon
Coca-Cola
KO
+$36M
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$31.9M
4
POST icon
Post Holdings
POST
+$26.8M
5
NOMD icon
Nomad Foods
NOMD
+$26.4M

Sector Composition

Rank Sector Weight
1 Healthcare 33.06%
2 Consumer Staples 5.21%
3 Consumer Discretionary 4.94%
4 Technology 3.72%
5 Materials 0.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GRI
226
GRI Bio
GRI
$2.85M
$96.4K ﹤0.01%
+105
New +$250K
FEED
227
ENvue Medical Inc
FEED
$2.22M
$95.8K ﹤0.01%
1,244
-1,037
-45% -$88.3K
MTEKW icon
228
Maris-Tech Ltd Warrants
MTEKW
$1.16M
$94.6K ﹤0.01%
1,261,058
– –
SKYAW
229
SkyAI Inc
SKYAW
$263K
$85.8K ﹤0.01%
1,176,000
– –
AVGR
230
DELISTED
Avinger, Inc. Common Stock
AVGR
$81.4K ﹤0.01%
+43,747
New +$132K
SQFTW icon
231
Presidio Property Trust Inc Series A Warrants
SQFTW
$198K
$78K ﹤0.01%
2,000,000
– –
MYSZ icon
232
My Size
MYSZ
$1.89M
$68.6K ﹤0.01%
+26,000
New +$95.6K
DRMA icon
233
Dermata Therapeutics
DRMA
$4.46M
$66.9K ﹤0.01%
+2,800
New +$122K
LCFYW icon
234
Locafy Ltd Warrant
LCFYW
$363K
$66.7K ﹤0.01%
12,121
– –
BIAFW icon
235
bioAffinity Technologies
BIAFW
$112K
$61.3K ﹤0.01%
204,082
– –
NXTC icon
236
NextCure
NXTC
$21.9M
$57.2K ﹤0.01%
+3,000
New +$58.3K
DCOY
237
Decoy Therapeutics
DCOY
$2.34M
$54.1K ﹤0.01%
126
+68
+117% +$44.9K
SBEV.WS
238
DELISTED
Splash Beverage Group, Inc. Warrants to purchase 1/40th of a share of Common Stock at an exercise price of $184.00
SBEV.WS
$51.7K ﹤0.01%
904,000
– –
STAF
239
DELISTED
Staffing 360 Solutions, Inc. Common Stock (DE)
STAF
$35.5K ﹤0.01%
16,900
-23,300
-58% -$68.5K
MOBBW
240
Mobilicom Ltd Warrants
MOBBW
$2.41B
$31.5K ﹤0.01%
242,100
– –
NLSPW
241
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$17.3K ﹤0.01%
500,000
– –
SWAGW icon
242
Stran & Company Warrant
SWAGW
$108K
$16.4K ﹤0.01%
545,000
– –
SVREW
243
SaverOne 2014 Ltd Warrant
SVREW
$48.9K
$15.1K ﹤0.01%
242,100
– –
RVSNW icon
244
Rail Vision Ltd Warrant
RVSNW
$744K
$10.9K ﹤0.01%
136,187
– –
TNONW icon
245
Tenon Medical Inc Warrant
TNONW
$1.68K
$8.88K ﹤0.01%
178,000
– –
IVDAW icon
246
Iveda Solutions Warrant
IVDAW
$36.4K
$6.53K ﹤0.01%
145,000
– –
DFSCW
247
DEFSEC Technologies Warrant
DFSCW
$63.1K
$3.18K ﹤0.01%
120,000
– –
NEXRW
248
Nexera Technologies Ltd Warrant
NEXRW
$36K
$2.2K ﹤0.01%
68,682
+1
+0% –
ACONW icon
249
Aclarion Warrant
ACONW
$61.2K
$1.25K ﹤0.01%
34,375
– –
KTTAW icon
250
Pasithea Therapeutics Warrants
KTTAW
$11.1K
$995 ﹤0.01%
50,000
– –
8 9
10
11 12

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Armistice Capital held 409 positions worth $7.95B, up 5.4% from $7.54B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Armistice Capital deployed $737M of net new capital in Q2 2024, opening 72 new positions and adding to 88 existing holdings. Its largest new stake was Simply Good Foods: 957,163 shares worth $34.6M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Coca-Cola, an estimated $36M trimmed.

  • Armistice Capital's largest Q2 2024 buy was Simply Good Foods: 957,163 shares worth $34.6M.
  • Armistice Capital added most to Alkermes in Q2 2024, an estimated $49.7M increase.
  • Armistice Capital's biggest Q2 2024 reduction was Coca-Cola, cutting an estimated $36M.
  • Armistice Capital fully exited Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2024, selling an estimated $92.8M.
  • Armistice Capital's ten largest holdings make up 63% of its $7.95B portfolio in Q2 2024.
  • Armistice Capital opened 72 new positions and closed 155 in Q2 2024.
  • Armistice Capital's portfolio value rose 5.4% quarter-over-quarter to $7.95B.

Based on Armistice Capital's 13F filing for Q2 2024, filed 14 Aug 2024.